Literature DB >> 15027327

[Effect of concurrent treatment of SSRI on the tyrosine hydroxylase immunoreactivity in the rat locus coeruleus treated with chronic variable stress].

Sachiko Fujii1, Mikio Asakura, Shigeto Kanai, Daisuke Tanaka, Takuji Hishinumai, Hideaki Nagashima.   

Abstract

Locus coeruleus (LC) is the major component of noradrenergic neurons in the brain. corticotropine-releasing hormone (CRH) and norepinephrine (NE) are suggested to play significant roles in the pathophysiology of depression, although the involvement of the serotonergic system in the CRH-NE systems is not elucidated. Chronic inescapable and unpredictable stress can result in a sustained dysregulation of both of CRH and NE systems. In the present study we have investigated the TH immunoreactivity in the LC by immunohistochemical staining in rats treated with chronic variable stress (CVS) and concurrent administration with clomipramine or fluvoxamine. There was a significant decrease in TH levels 24 h after the last stressor of CVS, followed by a further decrease in that of 72 h later, whereas a marked increase was observed in TH levels immediately after the last stress of CVS 13 d. Concurrent clomipramine and fluvoxamine treatment prevented the sensitization of TH reactivity and the delayed decrease until 72 h later. These data suggest that an increase in serotonin availability would contribute to the normalization of both hypoactivity and sensitization of LC-NE neurons modified under "chronically stressful" situations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027327

Source DB:  PubMed          Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi        ISSN: 1340-2544


  1 in total

1.  Quantification of Tyrosine Hydroxylase and ErbB4 in the Locus Coeruleus of Mood Disorder Patients Using a Multispectral Method to Prevent Interference with Immunocytochemical Signals by Neuromelanin.

Authors:  Lei Guo; Jochem Stormmesand; Zheng Fang; Qingbin Zhu; Rawien Balesar; Joop van Heerikhuize; Arja Sluiter; Dick Swaab; Ai-Min Bao
Journal:  Neurosci Bull       Date:  2019-01-31       Impact factor: 5.203

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.